Ochoa A C, Migliori R J, Alter B J, Sondel P M, Simmons R L, Bach F H
Department of Lab Medicine, University of Minnesota, Minneapolis 55455.
Prog Clin Biol Res. 1987;244:289-99.
Long-term culture of cells in rIL2-containing medium increases LAK activity on a per cell basis and produces an average 30-100-fold expansion over 14-21 days. The stimulation of PBL with anti-CD3 results in a 300-1000-fold increase in cell number while maintaining LAK activity. Cells stimulated with anti-CD3 and cultured in rIL2 for 12 days) can be further stimulated with beta IL1, or beta IFN, producing a further increase in LAK activity. These findings have allowed us to begin understanding the role of different signals in the activation of cells with LAK activity and together with biotechnological advances will allow for the culture of large numbers of cells for experimental and therapeutic purposes.
在含重组白细胞介素-2(rIL2)的培养基中长期培养细胞,可使单个细胞的淋巴因子激活的杀伤细胞(LAK)活性增加,并在14 - 21天内实现平均30 - 100倍的扩增。用抗CD3刺激外周血淋巴细胞(PBL),可使细胞数量增加300 - 1000倍,同时保持LAK活性。用抗CD3刺激并在rIL2中培养12天的细胞,可进一步用β白细胞介素-1(βIL1)或β干扰素(βIFN)刺激,从而使LAK活性进一步增加。这些发现使我们能够开始了解不同信号在激活具有LAK活性的细胞中的作用,并且随着生物技术的进步,将能够培养大量细胞用于实验和治疗目的。